From the CETIR Unidad PET/TC, Barcelona, Spain.
Clin Nucl Med. 2014 Aug;39(8):742-3. doi: 10.1097/RLU.0000000000000495.
The main indication for C-choline PET/CT in prostate cancer patients is the early localization of biochemical recurrence after radical treatment. However, any C-choline uptake should be assessed in terms of physiological distribution and patterns of tumor spread. Therefore, tracer-avid lesions in unexpected sites should be carefully addressed because the diagnosis of other malignancies has important therapeutic implications. We present a patient with biochemical recurrence of prostate cancer treated with radiotherapy. C-choline PET/CT showed local recurrence and inguinal lymph node uptake. Because of its location beyond typically prostatic lymphatic spread, resection was performed. Histology confirmed a diffuse large B-cell lymphoma.
C-胆碱 PET/CT 在前列腺癌患者中的主要适应证是根治性治疗后生化复发的早期定位。然而,任何 C-胆碱摄取都应根据生理分布和肿瘤扩散模式进行评估。因此,应仔细处理意外部位摄取示踪剂的病变,因为其他恶性肿瘤的诊断具有重要的治疗意义。我们报告了一位接受放疗治疗的前列腺癌生化复发患者。C-胆碱 PET/CT 显示局部复发和腹股沟淋巴结摄取。由于其位置超出了通常的前列腺淋巴扩散范围,因此进行了切除。组织学证实为弥漫性大 B 细胞淋巴瘤。